Affiliation:
1. Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea
2. School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
3. Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA
4. AmtixBio Co., Ltd., Hanam-si, Gyeonggi-do, South Korea
Abstract
The casein kinase 2 (CK2) complex, crucial for eukaryotic growth, differentiation, and metabolic regulation, presents a promising therapeutic target for various human diseases, including cancer, diabetes, and obesity. Its potential as an antifungal target is further highlighted in this study, which explores CK2’s functions in
C. neoformans
, a key fungal meningitis pathogen. The CK2 complex in
C. neoformans
, comprising the Cka1 catalytic subunit and Ckb1/2 regulatory subunits, is integral to processes like growth, cell cycle, morphogenesis, stress response, drug resistance, and virulence. Our findings of CK2’s role in regulating critical signaling pathways, including Hog1, Mpk1 MAPKs, cAMP/PKA, and calcium/calcineurin, underscore its importance in
C. neoformans
pathogenicity. This study provides valuable insights into the fungal CK2 complex, reinforcing its potential as a target for novel antifungal drug development and pointing out a promising direction for creating new antifungal agents.
Funder
National Research Foundation of Korea
Yonsei Signature Research Cluster Program
National Institute of Health (NIH)/National Institute of Allergy and Infectious Disease
Publisher
American Society for Microbiology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献